Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000180

Chief Business Officer gave up 9,004 shares (to pay taxes)

  • Chief Business Officer acquired 200,000 shares (grant or award)
  • Chief Business Officer acquired 25,950 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Boyle Scott N Chief Business Officer 2026-02-13 Grant or award +200,000 307,805 D: show line 1 in the form
Boyle Scott N Chief Business Officer 2026-02-13 Option exercise +5,000 307,805 D: show line 2 in the form
Boyle Scott N Chief Business Officer 2026-02-13 Shares withheld for taxes −1,735 $1.89 $3,279 306,070 D: show line 3 in the form
Boyle Scott N Chief Business Officer 2026-02-14 Option exercise +20,950 306,070 D: show line 4 in the form
Boyle Scott N Chief Business Officer 2026-02-14 Shares withheld for taxes −7,269 $1.89 $13,738 298,801 D: show line 5 in the form
Loading xslF345X05/wk-form4_1771452315.xml…